Substance / Medication

Oxacillin sodium

Overview

Active Ingredient
oxacillin
RxNorm CUI
7773

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

135 trials linked to this intervention

135
Total Trials
28
Recruiting
20
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Case of acute generalized exanthematous pustulosis caused by ampicillin/cloxacillin sodium in a pregnant woman.
Matsumoto Yuka, Okubo Yukari, Yamamoto Toshiyuki et al. · J Dermatol · 2008
PMID: 18578714Case Report
Separation and characterization of the polymerized impurities in oxacillin sodium by 2D HPSEC and HPLC IT-TOF MS.
Gao Jiarui, Wang Fan, Zhang Xiangyu et al. · Rapid Commun Mass Spectrom · 2023
PMID: 36597914Other
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration.
Sullivan Thomas, Forest Jean-Marc, Leclair Grégoire · Hosp Pharm · 2015
PMID: 26405311OtherFull text (PMC)
Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Cloxacillin Sodium in Its Bulk Form and Formulation.
Patel Nikita, Contractor Pooja, Keshrala Rajesh et al. · J Chromatogr Sci · 2015
PMID: 25368408Other
Polymorphism of flucloxacillin sodium.
Zhou Xiao-Yin, Liu Zheng, Wang Miao-Miao et al. · Pharmazie · 2011
PMID: 22312697Other
A novel spectrophotometric method for the determination oxacillin sodium.
Gujral Rajinder Singh, Haque Sk Manirul, Shanker Prem · Int J Biomed Sci · 2009
PMID: 23675161OtherFull text (PMC)
Preparation and study on the solid inclusion complex of cloxacillin sodium with beta-cyclodextrin.
Chao Jian-Bin, Zhang Bing-Tai · Spectrochim Acta A Mol Biomol Spectrosc · 2007
PMID: 17321790Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Oxacillin sodium (substance)
SNOMED CT
85724000
UMLS CUI
C0037536
RxNorm CUI
7773

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

11
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
135
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.